TrialTargeted oncology2019
Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial.
Ali A Mokdad et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papertrialcites it